# US 2024/0215984 A1 · Systems, programs and methods for determining when to terminate a coronary sinus occlusion treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0215984 A1
- Document ID: US20240215984A1
- Status: Published application
- Kind: A1
- Application number: 18/286,065
- Filed: 2021-04-08
- Published: 2024-07-04
- Earliest claimed: 2021-04-08
- Assignees: Miracor Medical SA
- Applicants: Miracor Medical SA
- Inventors: Jozef TANCZOS; Ventzeslav IORDANOV; Werner MOHL
- Web page: https://patentgrep.com/patent/US20240215984A1

## CPC

- A61B 17/12122: {within the heart (for closing a cardiac septal defect A61B17/0057)}
- A61M 60/143: inside the coronary sinus, e.g. for pressure-controlled intermittent coronary sinus occlusion
- A61B 5/02028: {Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction}
- A61B 5/02152: {specially adapted for venous pressure}
- A61B 17/1204: {temporary occlusion}
- A61B 17/12109: {in a blood vessel}
- A61B 17/12136: {Balloons}
- A61M 60/295: Balloon pumps for circulatory assistance
- A61M 60/32: of heart muscle tissues, e.g. using coronary sinus occlusion
- A61M 60/515: Regulation using real-time patient data
- A61M 60/523: using blood flow data, e.g. from blood flow transducers
- A61M 60/531: using blood pressure data, e.g. from blood pressure sensors
- A61B 2017/00022: {Sensing or detecting at the treatment site}
- A61B 2017/00044: {Sensing electrocardiography, i.e. ECG}
- A61B 2017/00084: {Temperature}
- A61B 2017/00128: {related to intensity or progress of surgical action}
- A61B 2017/00137: {Details of operation mode}
- A61B 2017/00172: {Pulse trains, bursts, intermittent continuous operation}
- A61B 2017/00199: {with a console, e.g. a control panel with a display}
- A61B 2090/064: {for measuring force, pressure or mechanical tension}
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61M 2025/1052: {for temporarily occluding a vessel for isolating a sector}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A system includes a coronary sinus occlusion device operable to occlude at least a portion of a coronary sinus of a heart of a patient, and a control system that activates the coronary sinus occlusion device and generates a user prompt on a user interface to terminate a coronary sinus occlusion treatment in response to a detected condition.

## Claims

### Claim 1

A system comprising:
a coronary sinus occlusion device operable to occlude at least a portion of a coronary sinus of a heart of a patient; and
a control system connectable to the coronary sinus occlusion device and configured to execute computer-readable instructions that perform operations including:
activating the coronary sinus occlusion device to intermittently occlude the coronary sinus during a plurality of occlusion phases of a coronary sinus occlusion treatment,
operating the coronary sinus occlusion device to release each intermittent occlusion of the coronary sinus during the coronary sinus occlusion treatment,
receiving sensor data signals indicative of a hemodynamics parameter of the heart during the plurality of occlusion phases,
comparing a threshold value to an indicator value that is based on the sensor data signals of the plurality of occlusion phases, and
terminating the coronary sinus occlusion treatment based on said comparing the threshold value to the value or providing a user prompt on a user interface to terminate the coronary sinus occlusion treatment based on said comparing the threshold value to the indicator value.

### Claim 2 (depends on 1)

The system of claim 1, wherein the coronary sinus occlusion device comprises:
an expandable member insertable into the coronary sinus and expandable to occlude at least the portion of the coronary sinus, and
a sensor that generates the sensor data signals.

### Claim 3 (depends on 2)

The system of claim 2, wherein the sensor is positioned near the expandable member.

### Claim 4 (depends on 2)

The system of claim 2, wherein the coronary sinus occlusion device comprises a catheter, and the expandable member and the sensor are positioned on a distal portion of the catheter.

### Claim 5 (depends on 2)

The system of claim 2, wherein the sensor is a pressure sensor configured to measure a pressure or a rate of change of the pressure in the coronary sinus.

### Claim 6 (depends on 2)

The system of claim 2, wherein the sensor is configured to measure:
a flow rate in a coronary artery of the patient or a rate of change of the flow rate in the coronary artery of the patient;
a flow rate in a coronary venous system distal to a distal end of the coronary sinus occlusion device or a rate of change of the flow rate in the coronary venous system;
a coronary wedge pressure associated with the coronary sinus occlusion device or a rate of change of the coronary wedge pressure;
a density or viscosity of blood in the coronary venous system or a rate of change of the density or viscosity;
a temperature of a fluid injected into a coronary sinus of the patient or a rate of change of the temperature of the fluid;
a quantitative flow ratio of microcirculation or a rate of change of the quantitative flow ratio;
a microvascular resistance in the coronary sinus or a rate of change of the microvascular resistance; or
any combination thereof.

### Claim 7 (depends on 6)

The system of claim 6, wherein the sensor is a first sensor, the sensor data signals are first sensor data signals, and the coronary sinus occlusion device further comprises a second sensor configured to generate second sensor data signals indicative of a pressure or a rate of change of the pressure in the coronary sinus, and the indicator value is based on the first sensor data signals and the second sensor data signals.

### Claim 8 (depends on 1)

The system of claim 1, wherein the coronary sinus occlusion device comprises:
an expandable member insertable into the coronary sinus and expandable to occlude at least the portion of the coronary sinus,
a first sensor that generates at least some of the sensor data signals, and
a second sensor that generates at least some of the sensor data signals, wherein the first and second sensors are positioned on first and second sides of the expandable member.

### Claim 9 (depends on 1)

The system of claim 1, wherein receiving the sensor data signals comprises receiving, from a sensor configured to measure the hemodynamics parameter in an arterial system of the heart, the sensor data signals.

### Claim 10 (depends on 1)

The system of claim 1, wherein the sensor data signals are indicative of a pressure or a rate of change of the pressure in the coronary sinus.

### Claim 11 (depends on 10)

The system of claim 10, wherein the operations include:
determining the indicator value based on, for each of the plurality of occlusion phases, a maximum value of the pressure or the rate of change of the pressure in the coronary sinus in a period of time during a corresponding occlusion phase.

### Claim 12 (depends on 11)

The system of claim 11, wherein, for each of the plurality of occlusion phases, the period of time corresponds to an end period of the corresponding occlusion phase.

### Claim 13 (depends on 10)

The system of claim 10, wherein the operations include:
determining the indicator value based on, for each of the plurality of occlusion phases, an average value of the pressure or the rate of change of the pressure in the coronary sinus in a period of time during a corresponding occlusion phase.

### Claim 14 (depends on 1)

The system of claim 1, wherein said terminating the coronary sinus occlusion treatment or providing the user prompt on the user interface to terminate the coronary sinus occlusion treatment is performed in response to a determination that a plurality of indicator values that are based on the sensor data signals of the plurality of occlusion phases are substantially in steady state, the plurality of indicator values comprising the indicator value.

### Claim 15 (depends on 14)

The system of claim 14, wherein the operations include:
predicting a value of the hemodynamics parameter, wherein the indicator value corresponds to a difference between at least one of the plurality of indicator values and the predicted value.

### Claim 16 (depends on 15)

The system of claim 15, wherein the at least one of the plurality of indicator values corresponds to a last indicator value of the plurality of indicator values.

### Claim 17 (depends on 15)

The system of claim 15, wherein the difference is a percent difference between the at least one of the plurality of indicator values and the predicted value.

### Claim 18 (depends on 15)

The system of claim 15, wherein the threshold value is no less than 1 percent and is no more than 5 percent.

### Claim 19 (depends on 18)

The system of claim 18, wherein the operations include:
determining the threshold value based on one or more of a condition of the patient or a type of the coronary sinus occlusion treatment.

### Claim 20 (depends on 1)

The system of claim 1, wherein the operations include:
after providing the user prompt on to terminate the coronary sinus occlusion treatment, terminating the coronary sinus occlusion treatment only if at least a duration of the coronary sinus occlusion treatment is no less than a threshold duration.

### Claim at position 21

-28. (canceled)
